Epignostix

Visit website

overall

19,660

out of 63,194

-5315

traffic

18,217

out of 63,194

-2233

investment

4,197

out of 63,194

-9

review

Not Available

These rankings are based on data from July 2026

Company

Heidelberg Epignostix GmbH

Years in business

Number of employees

1-10 employees

Country

Germany

Heidelberg Epignostix leverages DNA methylation and machine learning to enhance cancer diagnostics, enabling precise tumor classification. Established in 2022, it focuses on transforming cancer care with innovative molecular diagnostics solutions.

API Availability

Pricing

unknown

Use

ai cancer detection

ai disease diagnosis

Position of Epignostix on sub rankings

July 2026

AI cancer detection - Overall

20 out of 32

AI disease diagnosis - Overall

90 out of 159

Germany - Overall

943 out of 1,877

AI cancer detection - Overall

20 out of 32

AI disease diagnosis - Overall

90 out of 159

Germany - Overall

943 out of 1,877

Industries

health & sports

research & development

Company

Heidelberg Epignostix GmbH

Years in business

Number of employees

1-10 employees

Country

Germany

Help us improve this profile

Insights

5 New AI Tools: From the trading desk to the therapy room

Five new tools from our submission queue, each built for one job and close to useless to anyone outside it, from the trading desk to the therapy room.

Data-Driven Policy: How the Province of Zuid-Holland uses RankmyAI to map its AI economy

The Province of Zuid-Holland maps the AI activity in the region with data from RankmyAI, together with the cities of Rotterdam and The Hague and development agency InnovationQuarter. A conversation with Bart Spee, Policy Officer for the Digital Economy, about the overview that was missing, an unexpected sector, and what he wants to know next.